[Adrenal ablation therapy for primary aldosteronism related resistant hypertension: key technology and clinical application perspectives].

Zhu, Z M; Zhao, Z G; Zhang, H X; He, H B; Yan, Z C

Zhu, Z M; Zhao, Z G; Zhang, H X; He, H B; Yan, Z C.

Afiliación

Zhu ZM; Department of Hypertension and Endocrinology, Center for Hypertension and Metabolic Diseases, Daping Hospital, Army Medical University, Chongqing Key Laboratory for Cardiometabolic Diseases,Chongqing 400042, China.
Zhao ZG; Department of Hypertension and Endocrinology, Center for Hypertension and Metabolic Diseases, Daping Hospital, Army Medical University, Chongqing Key Laboratory for Cardiometabolic Diseases,Chongqing 400042, China.
Zhang HX; Department of Hypertension and Endocrinology, Center for Hypertension and Metabolic Diseases, Daping Hospital, Army Medical University, Chongqing Key Laboratory for Cardiometabolic Diseases,Chongqing 400042, China.
He HB; Department of Hypertension and Endocrinology, Center for Hypertension and Metabolic Diseases, Daping Hospital, Army Medical University, Chongqing Key Laboratory for Cardiometabolic Diseases,Chongqing 400042, China.
Yan ZC; Department of Hypertension and Endocrinology, Center for Hypertension and Metabolic Diseases, Daping Hospital, Army Medical University, Chongqing Key Laboratory for Cardiometabolic Diseases,Chongqing 400042, China.

Zhonghua Xin Xue Guan Bing Za Zhi ; 49(10): 951-956, 2021 Oct 24.

Article en Zh | MEDLINE | ID: mdl-34674432

Asunto(s)

Hiperaldosteronismo; Hipertensión; Humanos; Hiperaldosteronismo/complicaciones; Hiperaldosteronismo/cirugía; Hipertensión/tratamiento farmacológico; Tecnología

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hiperaldosteronismo / Hipertensión Límite: Humans Idioma: Zh Revista: Zhonghua Xin Xue Guan Bing Za Zhi Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google